A cryptotope is an antigenic site or epitope hidden in a protein or virion by surface subunits. Cryptotopes are antigenically active only after the dissociation of protein aggregates and virions. [1] Some infectious pathogens are known to escape immunological targeting by B-cells by masking antigen-binding sites as cryptotopes. [2] A cryptotope can also be referred to as a cryptic epitope. Cryptotopes are becoming important for HIV vaccine research as a number of studies have shown that cryptic epitopes can be revealed or exposed when HIV gp120 binds to CD4. [3]
References
- ^ Regenmortel, Marc (2008). "Antigenicity and Immunogenicity of Viral Proteins" (PDF). Elsevier.
- ^ Reider, Franz; Biebl, Julia; et al. (22 July 2016). "Microbial Cryptotopes are Prominent Targets of B-cell Immunity". Scientific Reports. 6: 31657. doi: 10.1038/srep31657. PMC 4990913. PMID 27539094.
- ^ Thali, Marcus (July 1993). "Characterization of Conserved Human Immunodeficiency Virus Type 1 gpl20 Neutralization Epitopes Exposed upon gpl20-CD4 Binding". Journal of Virology. 67 (7). American Society for Microbiology: 3978–3988. doi: 10.1128/jvi.67.7.3978-3988.1993. PMC 237765. PMID 7685405.
 | This immunology article is a stub. You can help Wikipedia by expanding it. |
A cryptotope is an antigenic site or epitope hidden in a protein or virion by surface subunits. Cryptotopes are antigenically active only after the dissociation of protein aggregates and virions. [1] Some infectious pathogens are known to escape immunological targeting by B-cells by masking antigen-binding sites as cryptotopes. [2] A cryptotope can also be referred to as a cryptic epitope. Cryptotopes are becoming important for HIV vaccine research as a number of studies have shown that cryptic epitopes can be revealed or exposed when HIV gp120 binds to CD4. [3]
References
- ^ Regenmortel, Marc (2008). "Antigenicity and Immunogenicity of Viral Proteins" (PDF). Elsevier.
- ^ Reider, Franz; Biebl, Julia; et al. (22 July 2016). "Microbial Cryptotopes are Prominent Targets of B-cell Immunity". Scientific Reports. 6: 31657. doi: 10.1038/srep31657. PMC 4990913. PMID 27539094.
- ^ Thali, Marcus (July 1993). "Characterization of Conserved Human Immunodeficiency Virus Type 1 gpl20 Neutralization Epitopes Exposed upon gpl20-CD4 Binding". Journal of Virology. 67 (7). American Society for Microbiology: 3978–3988. doi: 10.1128/jvi.67.7.3978-3988.1993. PMC 237765. PMID 7685405.
|
| This immunology article is a stub. You can help Wikipedia by expanding it. |